1
by Ho, Chuong, Campbell, Kaitryn, Grobelna, Aleksandra
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Medical History Taking...

2
Published 2016
CADTH
..., for the prevention of atherothrombotic events in adult patients with a history of myocardial infarction that occurred...

3
Published 2016
CADTH
..., for the prevention of atherothrombotic events in adult patients with a history of myocardial infarction that occurred...

4
Published 2016
CADTH
...), for the secondary prevention of atherothrombotic events in adult patients with a history of myocardial infarction...

5
Published 2014
Canadian Agency for Drugs and Technologies in Health
... effect and high) than diazepam among RCT participants with a history of drug and alcohol abuse. A review...

6
by Williams, D., Gray, Casey, Picheca, Lory
Published 2019
CADTH
... lymphoma, irrespective of eligibility for or prior history of autologous stem cell transplantation...

7
Published 2016
Canadian Agency for Drugs and Technologies in Health
... of atherothrombotic events in patients with a history (occurred at least one year ago) of myocardial infarction (MI...

8
Published 2016
Canadian Agency for Drugs and Technologies in Health
... of atherothrombotic events in patients with a history (occurred at least one year ago) of myocardial infarction (MI...

9
by Williams, D., Gray, Casey, Picheca, Lory
Published 2019
CADTH
... lymphoma, irrespective of eligibility for or prior history of autologous stem cell transplantation...

10
Published 2014
Canadian Agency for Drugs and Technologies in Health
... of which are articulating discs. Given the challenging history of lumbar surgery and the variation...

11
Published 2014
Canadian Agency for Drugs and Technologies in Health
... of which are articulating discs. Given the challenging history of lumbar surgery and the variation...

12
by Richardson, Marina
Published 2016
Canadian Agency for Drugs and Technologies in Health
...), and monitoring post-operative patients with a history of sleep apnea or who have received high doses of opioids...

13
Published 2017
Canadian Agency for Drugs and Technologies in Health
... among affected muscles in patients with and without a prior history of treatment with botulinum toxin...

14
by Richardson, Marina
Published 2016
Canadian Agency for Drugs and Technologies in Health
...), and monitoring post-operative patients with a history of sleep apnea or who have received high doses of opioids...

15
Published 2015
Canadian Agency for Drugs and Technologies in Health
... for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture...

16
by Assasi, Nazila
Published 2016
CADTH
... may be pre-screened for potential hereditary CRC based on age or family history, followed by testing...

17
by Assasi, Nazila
Published 2016
CADTH
... may be pre-screened for potential hereditary CRC based on age or family history, followed by testing...

18
by Assasi, Nazila, Blackhouse, Gord, Campbell, Kaitryn, Weeks, Laura Christine
Published 2015
Canadian Agency for Drugs and Technologies in Health
... and desirable option given the known limitations of Lynch syndrome pre-selection criteria based on age, history...

20
Published 2020
Canadian Agency for Drugs and Technologies in Health
... made about the natural history of gMG and the anticipated use of eculizumab. Together, these introduce...